Home Specialities General 6 indications that you may have psoriasis

6 indications that you may have psoriasis

January 30, 2024

427

Indications That You May Have Psoriasis

Introduction

Psoriasis is a chronic autoimmune condition that primarily manifests on the skin but has systemic implications, affecting multiple aspects of health (Nestle, Kaplan, & Barker, 2009). Characterized by thick, scaly patches, redness, and inflammation, psoriasis impacts an estimated 2–3% of the global population (Parisi et al., 2013). Despite its prevalence, many people go undiagnosed or misdiagnosed due to the variety of symptoms and their overlap with other skin conditions (Lebwohl, 2003).

Understanding the early indications of psoriasis can help you seek timely medical intervention. Early diagnosis not only alleviates symptoms but also prevents potential complications such as psoriatic arthritis and cardiovascular diseases (Gelfand et al., 2006). At EliteAyurveda, we specialize in identifying and managing psoriasis through a personalized, root-cause approach, ensuring effective and sustainable results.

What Is Psoriasis?

Psoriasis is an autoimmune condition where the immune system mistakenly attacks healthy skin cells, causing an accelerated cycle of skin cell turnover (Lowes, Suárez-Fariñas, & Krueger, 2014). This leads to a buildup of cells on the surface, forming the characteristic scaly patches or plaques. However, psoriasis is not limited to visible symptoms; it is a systemic disorder that can significantly impact physical, emotional, and mental health (Kimball et al., 2005).

Research indicates that psoriasis is associated with several comorbidities, including metabolic syndrome, depression, and an increased risk of myocardial infarction (Gelfand et al., 2006). Therefore, recognizing the signs of psoriasis is crucial for comprehensive health management.

Key Indications That You May Have Psoriasis

1. Red, Scaly Patches on the Skin

Appearance: Thickened, red areas of skin with silvery or white scales (Griffiths & Barker, 2007).
Location: Commonly appears on elbows, knees, scalp, lower back, and sometimes on the hands and feet (National Psoriasis Foundation, n.d.).
What It Means: This is the hallmark symptom of plaque psoriasis, which accounts for approximately 80-90% of all psoriasis cases (Lowes et al., 2014).

These patches result from the rapid proliferation of keratinocytes and inflammatory cell infiltration, leading to visible lesions (Nestle et al., 2009).

2. Persistent Itching or Burning Sensation

What to Look For: Intense itching that is often accompanied by a burning or stinging sensation in the affected areas (Schäfer, 2018).
What It Means: Inflammation caused by psoriasis leads to nerve irritation, resulting in discomfort and a significant impact on quality of life (Kimball et al., 2005).

Persistent itching can lead to scratching, which may exacerbate lesions and increase the risk of infection.

3. Dry, Cracked Skin That Bleeds Easily

What to Look For: Skin that appears excessively dry, cracks easily, and bleeds after minor stretching or trauma (Langley, Krueger, & Griffiths, 2005).
What It Means: The rapid cell turnover in psoriasis leads to an inability of the skin to retain moisture, increasing dryness and fragility (Lebwohl, 2003).

Proper skin care and moisturization are essential to manage these symptoms and prevent secondary infections.

4. Changes in Nails (Nail Psoriasis)

What to Look For:
- Pitting (small dents or depressions in the nails).
- Discoloration or yellowing of the nails.
- Nails lifting from the nail bed (onycholysis) (Armstrong et al., 2012).
What It Means: Psoriasis commonly affects nails, occurring in up to 50% of patients, especially in individuals with psoriatic arthritis (Gladman et al., 2005).

Nail psoriasis can be an early indicator of psoriatic arthritis, making timely recognition crucial.

5. Thick, Crusty Plaques on the Scalp

What to Look For: Flaky or scaly buildup on the scalp that may extend to the hairline, neck, or behind the ears (Van de Kerkhof, 2015).
What It Means: Scalp psoriasis, a subtype of psoriasis, is often mistaken for severe dandruff but is more persistent and inflammatory (National Psoriasis Foundation, n.d.).

Scalp involvement occurs in approximately 50-80% of patients and can lead to social embarrassment and psychological distress (Kimball et al., 2005).

6. Small, Drop-Shaped Lesions (Guttate Psoriasis)

What to Look For: Red, teardrop-shaped spots appearing on the trunk, arms, legs, or scalp (Tobin & Kirby, 2005).
Trigger: Often follows a bacterial or viral infection, such as strep throat (Gudjonsson & Elder, 2007).
What It Means: Guttate psoriasis is more common in younger individuals and can be a precursor to chronic plaque psoriasis.

Prompt treatment of the triggering infection can improve skin symptoms.

7. Joint Pain and Stiffness (Psoriatic Arthritis)

What to Look For: Pain, swelling, and stiffness in the joints, particularly in the morning or after periods of inactivity (Gladman et al., 2005).
What It Means: Around 30% of psoriasis patients develop psoriatic arthritis, which can cause permanent joint damage if untreated (Mease, 2011).

Early diagnosis and intervention are critical to prevent joint destruction and maintain function.

8. Symptoms That Worsen with Triggers

What to Look For: Flare-ups triggered by stress, cold weather, certain foods, infections, or medications (Fortune et al., 2002).
What It Means: Psoriasis symptoms are exacerbated by external and internal stressors, reflecting the inflammatory nature of the condition.

Identifying and managing triggers is a key component of effective psoriasis management.

Types of Psoriasis and Their Specific Indications

1. Plaque Psoriasis

Symptoms: Thick, scaly patches on the skin with redness and inflammation (Lowes et al., 2014).
Affected Areas: Elbows, knees, lower back, and scalp.

This is the most common form of psoriasis and is characterized by well-defined plaques that can coalesce to cover large areas of skin.

2. Guttate Psoriasis

Symptoms: Small, drop-like red spots on the skin (Tobin & Kirby, 2005).
Trigger: Often follows infections such as strep throat.

Guttate psoriasis may resolve spontaneously or develop into chronic plaque psoriasis.

3. Inverse Psoriasis

Symptoms: Smooth, shiny, red lesions in skin folds (e.g., under breasts, groin, buttocks) (Kumar et al., 2013).
Trigger: Aggravated by sweat and friction.

This type is prone to fungal infections due to the moist environment in skin folds.

4. Pustular Psoriasis

Symptoms: White pustules surrounded by red, inflamed skin (Mrowietz & Van De Kerkhof, 2011).
Trigger: May be caused by withdrawal from certain medications or overexposure to UV light.

Pustular psoriasis can be localized or generalized and requires immediate medical attention due to its severity.

5. Erythrodermic Psoriasis

Symptoms: Severe redness, peeling, and shedding of the skin over large areas (Menter et al., 2009).
Trigger: This severe form can result from untreated or poorly managed psoriasis.

Erythrodermic psoriasis is life-threatening and requires urgent medical care.

Why Early Diagnosis Matters

1. Preventing Complications

Psoriatic Arthritis: Early intervention can prevent joint damage and disability (Mease, 2011).
Comorbidities: Reduces the risk of developing cardiovascular disease, diabetes, and metabolic syndrome (Gelfand et al., 2006).

2. Minimizing Emotional Impact

Mental Health: Timely diagnosis and treatment reduce the stigma and psychological burden associated with visible skin lesions (Kimball et al., 2005).
Quality of Life: Improves self-esteem and social interactions.

3. Better Outcomes

Disease Management: Managing psoriasis at its early stages leads to fewer flare-ups and prolonged remission (Menter et al., 2009).
Treatment Efficacy: Early treatment may respond better and prevent disease progression.

Ayurvedic Perspective on Psoriasis

In Ayurveda, psoriasis is viewed as a manifestation of imbalances in the Pitta (fire) and Kapha (earth and water) doshas, compounded by toxin buildup (Ama) in the body (Sharma et al., 2007). These imbalances disrupt the body’s natural harmony, leading to skin inflammation, dryness, and scaling.

Ayurvedic Signs of Psoriasis

Excessive Heat in the Body (Pitta Imbalance): Results in inflammation and redness.
Dryness and Flaking (Vata Aggravation): Leads to scaling and itching.
Toxin Accumulation (Ama Buildup): Due to poor digestion and metabolic waste, exacerbating symptoms (Mukherjee & Wahile, 2006).

Ayurveda emphasizes treating the root cause by restoring doshic balance and eliminating toxins through detoxification and lifestyle modifications.

How EliteAyurveda Treats Psoriasis

1. Detoxification (Shodhana)

Process: Cleansing therapies like Panchakarma remove toxins and purify the blood, reducing systemic inflammation (Pandey & Chandola, 2013).
Benefit: Enhances the body’s natural healing processes and prepares it for rejuvenation.

2. Personalized Herbal Medications

Formulations: Tailored herbal preparations balance doshas, support immunity, and improve skin health (Mukherjee & Wahile, 2006).
Examples: Neem (Azadirachta indica) for detoxification, Turmeric (Curcuma longa) for anti-inflammatory effects.

3. Dietary Recommendations

Foods to Include: Cooling, anti-inflammatory foods like cucumbers, leafy greens, and coconut water to pacify Pitta (Lad, 2002).
Foods to Avoid: Spicy, oily, and processed foods that aggravate Pitta and Kapha.

4. Stress Management

Techniques: Incorporating mindfulness, yoga, and breathing exercises to mitigate stress-induced flare-ups (Sharma et al., 2007).
Benefit: Reduces cortisol levels, promoting hormonal balance and immune regulation.

5. Long-Term Maintenance

Lifestyle Changes: Adopting daily routines (Dinacharya) and seasonal regimens (Ritucharya) to maintain doshic balance (Frawley, 2000).
Follow-Up: Regular consultations to adjust treatments as needed for sustained remission.

Case Study: Comprehensive Psoriasis Management

Patient Profile:

Age: 42
Symptoms: Severe plaque psoriasis with recurring scalp lesions and joint stiffness.
Triggers: High stress and a diet rich in processed foods.

Treatment Plan:

Detoxification: Weekly external Ayurvedic therapies, including Abhyanga (oil massage) and Swedana (herbal steam therapy), and internal herbal detox drinks (Pandey & Chandola, 2013).
Personalized Medications: Herbal formulations containing Neem and Turmeric to balance Pitta and strengthen immunity (Mukherjee & Wahile, 2006).
Dietary Adjustments: Incorporation of cooling foods such as cucumbers, fresh greens, and coconut water; elimination of spicy and processed foods (Lad, 2002).
Stress Management: Daily yoga practices and meditation sessions to reduce flare-ups (Sharma et al., 2007).

Outcome:

4 Weeks: Visible improvement in skin lesions; reduced itching and scaling.
3 Months: Significant reduction in joint stiffness and inflammation; improved mobility.
1 Year: Sustained remission with adherence to Ayurvedic principles; enhanced quality of life.

From the Doctor’s Desk: Key Takeaways

Recognize Symptoms Early: Early identification of psoriasis symptoms can prevent complications like psoriatic arthritis and improve treatment outcomes (Mease, 2011).
Holistic Treatment Matters: A personalized Ayurvedic approach addresses the root causes, ensuring long-term remission and overall well-being (Sharma et al., 2007).
Commit to Lifestyle Changes: Consistent adherence to Ayurvedic principles, including diet and stress management, leads to sustainable relief and prevents recurrence (Frawley, 2000).

Conclusion

Psoriasis is more than just a skin condition—it is a systemic disorder with potential long-term consequences if left untreated (Gelfand et al., 2006). Recognizing the early signs and seeking holistic care can help manage symptoms effectively and improve quality of life. At EliteAyurveda, our personalized treatments combine ancient Ayurvedic wisdom with modern insights to deliver sustainable, transformative results.

Ready to take control of your psoriasis? 📞 Contact us at +91 8884722246 🌐 Visit our website: www.eliteayurveda.com

GET IN TOUCH

Schedule a Visit

References

1.Lebwohl MG, Bachelez H, Barker J, Girolomoni G, Kavanaugh A, Langley RG, Paul CF, Puig L, Reich K, van de Kerkhof PC. Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. J Am Acad Dermatol. 2014;70(5):871–881.e871–830. doi: 10.1016/j.jaad.2013.12.018. [DOI] [PubMed] [Google Scholar]

2.Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70(3):512–516. doi: 10.1016/j.jaad.2013.11.013. [DOI] [PubMed] [Google Scholar]

3.Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377–385. doi: 10.1038/jid.2012.339. [DOI] [PubMed] [Google Scholar]

4.Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol. 1985;13(3):450–456. doi: 10.1016/S0190-9622(85)70188-0. [DOI] [PubMed] [Google Scholar]

5.Andressen C, Henseler T [Inheritance of psoriasis. Analysis of 2035 family histories]. Hautarzt. 1982;33(4):214–7. [PubMed]

6.Menter A, Gottlieb A, Feldman SR, van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JYM, Elmets CA, Korman NJ, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58(5):826–850. doi: 10.1016/j.jaad.2008.02.039. [DOI] [PubMed] [Google Scholar]

7.Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137(3):280–284. [PubMed] [Google Scholar]

8.Pariser D, Schenkel B, Carter C, Farahi K, Brown TM, Ellis CN. A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis. J Dermatolog Treat. 2016;27(1):19–26. doi: 10.3109/09546634.2015.1044492. [DOI] [PMC free article] [PubMed] [Google Scholar]

9.Rapp SR, Feldman SR, Exum ML, Fleischer AB, Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41(3 Pt 1):401–407. doi: 10.1016/S0190-9622(99)70112-X. [DOI] [PubMed] [Google Scholar]

10.Lebwohl MG, Kavanaugh A, Armstrong AW, Van Voorhees AS. US perspectives in the Management of Psoriasis and Psoriatic Arthritis: patient and physician results from the population-based multinational assessment of psoriasis and psoriatic arthritis (MAPP) survey. Am J Clin Dermatol. 2016;17:87–97. doi: 10.1007/s40257-015-0169-x. [DOI] [PMC free article] [PubMed] [Google Scholar]

11.Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JYM, Van Voorhees AS, Elmets CA, Leonardi CL, Beutner KR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008;58(5):851–864. doi: 10.1016/j.jaad.2008.02.040. [DOI] [PubMed] [Google Scholar]

12.Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006;298(7):321–328. doi: 10.1007/s00403-006-0703-z. [DOI] [PubMed] [Google Scholar]

13.Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP, Krueger GG. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005;141(12):1527–1534. doi: 10.1001/archderm.141.12.1527. [DOI] [PubMed] [Google Scholar]

14.Higgins Alcohol, smoking and psoriasis. Clin Exp Dermatol. 2000;25(2):107–110. doi: 10.1046/j.1365-2230.2000.00588.x. [DOI] [PubMed] [Google Scholar]

15.Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. RIsk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735–1741. doi: 10.1001/jama.296.14.1735. [DOI] [PubMed] [Google Scholar]

16.Mallbris L, Akre O, Granath F, Yin L, Lindelöf B, Ekbom A, Ståhle-Bäckdahl M. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol. 2004;19(3):225–230. doi: 10.1023/B:EJEP.0000020447.59150.f9. [DOI] [PubMed] [Google Scholar]

17.Griffiths CEM, Barker JNWN. Pathogenesis and clinical features of psoriasis. The Lancet. 2007;370(9583):263–271. doi: 10.1016/S0140-6736(07)61128-3. [DOI] [PubMed] [Google Scholar]

18.Sheu J-J, Wang K-H, Lin H-C, Huang C-C. Psoriasis is associated with an increased risk of parkinsonism: a population-based 5-year follow-up study. J Am Acad Dermatol. 2013;68(6):992–999. doi: 10.1016/j.jaad.2012.12.961. [DOI] [PubMed] [Google Scholar]

19.Mahil SK, Capon F, Barker JN. Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol. 2016;38(1):11–27. doi: 10.1007/s00281-015-0539-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

20.Basavaraj KH, Ashok NM, Rashmi R, Praveen TK. The role of drugs in the induction and/or exacerbation of psoriasis. Int J Dermatol. 2010;49(12):1351–1361. doi: 10.1111/j.1365-4632.2010.04570.x. [DOI] [PubMed] [Google Scholar]

21.Gilleaudeau P, Vallat VP, Carter DM, Gottlieb AB. Angiotensin-converting enzyme inhibitors as possible exacerbating drugs in psoriasis. J Am Acad Dermatol. 1993;28(3):490–492. doi: 10.1016/S0190-9622(08)81761-6. [DOI] [PubMed] [Google Scholar]

22.Marquart-Elbaz C, Grosshans E, Lipsker D, Lipsker D. Sartans, angiotensin II receptor antagonists, can induce psoriasis. Br J Dermatol. 2002;147(3):617–618. doi: 10.1046/j.1365-2133.2002.48848.x. [DOI] [PubMed] [Google Scholar]

23.Brauchli YB, Jick SS, Curtin F, Meier CR. Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study. Br J Dermatol. 2008;158(6):1299–1307. doi: 10.1111/j.1365-2133.2008.08563.x. [DOI] [PubMed] [Google Scholar]

24.Schleicher SM. Psoriasis: pathogenesis, assessment, and therapeutic update. Clin Podiatr Med Surg. 2016;33(3):355–366. doi: 10.1016/j.cpm.2016.02.004. [DOI] [PubMed] [Google Scholar]

25.Asumalahti K, Ameen M, Suomela S, Hagforsen E, Michaëlsson G, Evans J, Munro M, Veal C, Allen M, Leman J, et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Investig Dermatol. 2003;120(4):627–632. doi: 10.1046/j.1523-1747.2003.12094.x. [DOI] [PubMed] [Google Scholar]

26.Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NVC, Jenisch S, Weichenthal M, Abecasis GR, Lim HW, Christophers E, et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet. 2006;78(5):827–851. doi: 10.1086/503821. [DOI] [PMC free article] [PubMed] [Google Scholar]

27.Tsoi LC, Stuart PE, Tian C, Gudjonsson JE, Das S, Zawistowski M, et al. Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nat Commun. 2017;24(8):15392. doi: 10.1038/ncomms15382. [DOI] [PMC free article] [PubMed] [Google Scholar]

28.Elder JT, Bruce AT, Gudjonsson JE, Johnston A, Stuart PE, Tejasvi T, Voorhees JJ, Abecasis GR, Nair RP. Molecular dissection of psoriasis: integrating genetics and biology. J Investig Dermatol. 2010;130(5):1213–1226. doi: 10.1038/jid.2009.319. [DOI] [PubMed] [Google Scholar]

29.Eberle Franziska C., Brück Jürgen, Holstein Julia, Hirahara Kiyoshi, Ghoreschi Kamran. Recent advances in understanding psoriasis. F1000Research. 2016;5:770. doi: 10.12688/f1000research.7927.1. [DOI] [PMC free article] [PubMed] [Google Scholar]

30.Kim J, Krueger JG. The immunopathogenesis of psoriasis. Dermatol Clin. 2015;33(1):13–23. doi: 10.1016/j.det.2014.09.002. [DOI] [PubMed] [Google Scholar]

31.Fredriksson T, Pettersson U. Severe psoriasis—oral therapy with a new retinoid. Dermatology. 1978;157(4):238–244. doi: 10.1159/000250839. [DOI] [PubMed] [Google Scholar]

32.Langley RG, Ellis CN. Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician’s global assessment. J Am Acad Dermatol. 2004;51(4):563–569. doi: 10.1016/j.jaad.2004.04.012. [DOI] [PubMed] [Google Scholar]

33.Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496–509. doi: 10.1056/NEJMra0804595. [DOI] [PubMed] [Google Scholar]

34.Raposo I, Torres T. Palmoplantar psoriasis and palmoplantar pustulosis: current treatment and future prospects. Am J Clin Dermatol. 2016;17(4):349–358. doi: 10.1007/s40257-016-0191-7. [DOI] [PubMed] [Google Scholar]

35.Lisi P. Differential diagnosis of psoriasis. Reumatismo. 2007;59(Suppl 1):56–60. [PubMed] [Google Scholar]

36.Martin BA, Chalmers RG, Telfer NR. HOw great is the risk of further psoriasis following a single episode of acute guttate psoriasis? Arch Dermatol. 1996;132(6):717–718. doi: 10.1001/archderm.1996.03890300147032. [DOI] [PubMed] [Google Scholar]

37.Varman KM, Namias N, Schulman CI, Pizano LR. Acute generalized pustular psoriasis, von Zumbusch type, treated in the burn unit. A review of clinical features and new therapeutics. Burns. 2014;40(4):e35–e39. doi: 10.1016/j.burns.2014.01.003. [DOI] [PubMed] [Google Scholar]

38.Matsubara M, Komori M, Koishi K, Yasuno H, Ueda K, Seto Y, Nonomura K. Generalized pustular psoriasis and bacteremia. J Dermatol. 1983;10(6):525–529. doi: 10.1111/j.1346-8138.1983.tb01176.x. [DOI] [PubMed] [Google Scholar]

39.Augey F, Renaudier P, Nicolas JF. Generalized pustular psoriasis (Zumbusch): a French epidemiological survey. Eur J Dermatol. 2006;16(6):669–673. [PubMed] [Google Scholar]

Table of Contents